.svg){kind=logo}
.svg)
PubPro helps medical affairs teams cut publication costs by up to 50% and reduce submission times from hours to minutes.
Publication planning is only one piece of a time-consuming drug approval process, but as we saw during the pandemic, the ability to move swiftly is a significant competitive advantage for pharmaceutical companies.
By automating critical publication planning workflows, PubPro helps increase the agility and speed of your approval process so you can get to market faster without compromising the integrity or safety of your products.
Many publication planning tools require medical affairs teams to adapt their unique, proprietary processes to fit the rigid confines of one-size-fits-all technology.
In an effort to adhere to their organization's SOPs, users eventually find themselves performing 30%+ of the process outside of the system. Forcing users to adopt clunky workarounds and switch between multiple applications reduces productivity and process visibility.
PubPro is configured to your unique SOPs, which means you can ensure every step in the process is conducted in a single application.
As the development of pharmaceutical products becomes more specialized and unique, the necessity for rigorous scientific integrity and meticulous regulatory oversight has never been more critical.
There is no room for errors or hiccups when potentially life-saving therapies are on the line.
PubPro helps medical affairs teams ensure their publication planning processes are air-tight and constantly adapting to ever-changing regulatory and business requirements.
